Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive form of the disease traditionally ...
Feb 19, 2026
0
9
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new Phase III randomized trial.
Sep 29, 2025
0
13
Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy. ...
Mar 28, 2025
0
25
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses that allowed for bladder ...
Feb 17, 2025
0
10
Final results from the SWOG S1011 randomized Phase III clinical trial, published in the New England Journal of Medicine, indicate patients undergoing surgery for localized muscle-invasive bladder cancer derive no significant ...
Oct 2, 2024
0
34
A first-in-human trial led by The University of Western Australia has found injecting an immunotherapy drug directly into the bladder wall to treat cancer is viable and safe.
Mar 14, 2024
0
66
Mount Sinai investigators have developed a new approach for treating invasive bladder cancer without the need for surgical removal of the bladder, according to a study published in Nature Medicine in September. Removing the ...
Oct 2, 2023
0
48
An extended lymphadenectomy—removal of additional lymph nodes beyond the extent of the standard procedure—in patients undergoing radical cystectomy (removal of bladder and nearby tissues) because of clinically localized muscle-invasive ...
May 30, 2023
0
47
For patients with advanced bladder cancer who are medically unfit for standard treatment, a new intravesical (inside the bladder) chemotherapy delivery system called TAR-200 is safe and shows initial evidence of effectiveness, ...
Apr 7, 2023
0
41
Cancer is the third most common cause of death in people with spinal cord injury (SCI), with bladder cancer being the second most common cancer after lung cancer. It is not uncommon for bladder cancer in SCI patients to be ...
Aug 22, 2022
0
76
